“He certainly has access to the data from EIND. And he's pretty friggin confident in this drug.”

Exactly, the EIND data, not blinded data from the ongoing S/C trial as some have hinted (or hope). He sent a simple tweet out and investors jumped on it as another signal that the S/C trial is going to be successful. Dr. Jay has not changed his tune since early this year on his thoughts regarding leronlimab and this tweet is no different and NOT an indication that he has seen the S/C data.